Aytu BioScience announces U.S. co-promotion agreement for Primsol

Aytu BioScience announces U.S. co-promotion agreement for Primsol

ENGLEWOOD -- Aytu BioScience , Inc.(OTCQX: AYTU), a commercial-stage specialty healthcare company focused on commercializing treatments for urological conditions, today announced the company... Read More

Tuesday March 29, 2016 0 comments Tags: Englewood, Aytu BioScience, Primsol, Josh Disbrow, Allegis Pharmaceuticals